A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population. Clin Drug Investig (2023). Jewell, J., Black, J., Ellis, M., Olsen, H., Iwanicki, J., Dart, R.
Trends in characteristics of prescription opioid-related poisonings among older adults in the United States, 2015-2021. Journal of Addiction Medicine, 2023; in press. Han BH, Jewell JS, Ding B, Wu NC, Cottler LB, Palamar JJ.
Trends in Characteristics of Fentanyl-Related Poisonings in the United States, 2015-2021. American Journal on Drug and Alcohol Abuse.Palamar JJ, Cottler LB, Goldberger BA, Severtson SG, Grundy DJ, Iwanicki JL, Ciccarone D.
Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic. Mutter R, Black J, Iwanicki J.
Clustering patterns in polysubstance mortality in the United States in 2017: a multiple correspondence analysis of death certificate data. Black JC, Rockhill KM, Dart RC, Iwanicki JL. Ann Epidemiol
Nonmedical use of gabapentin and opioid agonist medications in treatment-seeking individuals with opioid use disorder. Drug and Alcohol Dependence
Associations of transactional sex and sexually transmitted infections among treatment-seeking individuals with opioid use disorder. Ellis MS, Kasper ZA, Takenaka B, Buttram ME, Shacham E. Am J Prev Med
Changes in hydrocodone misuse exposures reported to US poison centers following rescheduling in 2014. Fischer LJ, Severtson SG, Gurrola MC, Iwanicki JL, Green JL, Dart RC.
Characteristics of poisonings involving ketamine in the United States, 2019–2021. J Psychopharmacol. Palamar JJ, Fitzgerald ND, Grundy DJ, Black JC, Jewell JS, Cottler LB.
Evaluation of cannabis use among US adults during the COVID-19 pandemic within different legal frameworks. JAMA Netw Open. Black JC, Amioka E, Iwanicki JL, Dart RC, Monte AA.
Association of medical stimulants with mortality in the US from 2010 to 2017Black JC, Bau GE, Iwanicki JL, Dart RC JAMA Intern Med.
Drug product dispensing and estimates of use in a general population survey as a signal detection problem Black JC, Forber A, Severtson SG, Rockhill K, May KP, Amioka E, Schwarz J, Iwanicki JL, Dart RC Pharmacoepidemioloyg & Drug Safety
Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study Black JC, Margolin ZR, Bau GE, Olson R, Iwanicki JL, Dart RC JMIR Public Health Surveill
Increasing rates of buprenorphine diversion in the United States, 2002 to 2019 Buttram ME, Kurtz SP, Margolin ZR, Severtson SG. Pharmacoepidemiology & Drug Safety
Measuring prescription opioid misuse and its consequences Dart RC, Iwanicki JL, Black JC, Olsen HA, Severtson SGBritish Pharmacological Society
Shifting Pathways of Stimulant Use Among Individuals With Opioid Use Disorder: A Retrospective Analysis of the Last Thirty Years Ellis MS, Kasper ZA, Scroggins S Front. Psychiatry
Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European CountriesFonseca F, Lenahan W, Dart RC, et al. Front Psychiatry
Non-medical use of benzodiazepines and GABA analogues in EuropeHockenhull J, Amioka E, Black JC, Forber A, Haynes CM, Wood DM, Dart RC, Dargan PIBr J Clin Pharmacol
Nonmedical use of benzodiazepines and Z-drugs in the UKHockenhull J, Black JC, Haynes CM, Rockhill K, Dargan PI, Dart RC, Wood DMBJCP
Prevalence and description of kratom (Mitragyna speciosa) use in the United States: A cross‐sectional studySchimmel J, Amioka E, Rockhill K, Haynes CM, Black JC, Dart RC, Iwanicki JLSSA
Early-readmission after Agonist Opioid Treatment in five European countries. A drug addiction health policy challenge?
Tramadol non-medical use in four European countries: A comparative analysisIwanicki JL, Schwarz J, May KP, Black JC, Dart RC.Drug Alcohol Depend. 2020 Oct 20
Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ERSevertson SG, Kreider SED, Amioka EC, Margolin ZR, Iwanicki JI, Dart RCPain Med. 2020
Online Conversation Monitoring to Understand the Opioid Epidemic: Epidemiological Surveillance StudyBlack JC, Margolin ZR, Olson RA, Dart RCJMIR Public Health Surveillance
Misuse of prescription medicines is as prevalent as the use of recreational drugs and novel psychoactive substances in SingaporeChan WL, Dargan PI, Haynes CM, Green JL, Black JC, Dart RC, Wood DMSingapore Med J
The impact of the prescription opioid epidemic on young children: Trends and mortalityWang GS, Olsen HA, Severtson SG, Green JL, Dart RCDrug Alcohol Depend
Polysubstance use: A broader understanding of substance use during the opioid crisisCicero TJ, Ellis MS, Kasper ZAAm J Public Health
Non-medical use of loperamide in the UK and USAWebb NE, Wood DM, Black JC, Amioka E, Dart RC, Dargan PIQJM
The impact of opioid use disorder on levels of educational attainment: Perceived benefits and consequencesEllis MS, Kasper ZA, Cicero TJDrug Alcohol Depend
Changes in mortality involving extended-release and long-acting opioids after implementation of a Risk Evaluation and Mitigation StrategyBlack JC, Bau GE, Rosen T, Cepeda MS, Wedin GP, Green JL, Dart RCPain Med
An online survey for pharmacoepidemiological investigation (Survey of Non-Medical Use of Prescription Drugs Program): validation studyBlack JC, Rockhill K, Forber A, Amioka E, May KP, Haynes CM, Dasgupta N, Dart RCJ Med Internet Res
Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid noncancer patientsCicero TJ et al.Postgrad Med J
Commentary on Mintz et al. (2019): Unintended or intended? Coming to grips with the opioid crisisDart RCAddiction
Causal inference for evaluating prescription opioid abuse using trend‐in‐trend designDasgupta N, Schwarz J, Hennessy S, Ertefaie A, Dart RCPharmacoepidemiol Drug Saf
Understanding multi‐pill ingestion of prescription opioids: Prevalence, characteristics, and motivationEllis MS, Cicero TJ, Dart RC, Green JL Pharmacoepidemiol Drug Saf
Nonmedical use of alprazolam in the UK: Results from a nationally representative surveyHockenhull J, Amioka E, Black JC, Haynes CM, Dargan PI, Dart RC, Wood DMBr J Clin Pharmacol
The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017Kurtz SP, Buttram ME, Margolin ZR, Wogenstahl KPharmacoepidemiol Drug Saf.
Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphoneLebin JA, Murphy DL, Severtson SG, Bau GE, Dasgupta N, Dart RCPharmacoepidemiol Drug Saf
Brief report: Characterization of marijuana use in us college students by state marijuana legalization status as reported to an online surveyWang GS, Haynes C, Besharat A, Lait ML, Green JL, Dart RC, Roosevelt GAm J Addict
Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS System Poison CentersButler et al.J Subst Abuse Treat
Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014Calcaterra SL et al.Clin Toxicol
Twin epidemics: The surging rise of methamphetamine use in chronic opioid usersEllis MS, Kasper ZA, Cicero TJDrug Alcohol Depend
Consistency between opioid-related mortality trends derived from poison center and National Vital Statistics System, United States, 2006-2016Iwanicki JL et al.Am J Public Health
Comparative rates of mortality and serious adverse effects among commonly prescribed opioid analgesicsMurphy DL, Lebin JA, Severtson SG, Olsen HA, Dasgupta N, Dart RCDrug Saf
UK survey of non-medical use of prescription drugs (NMURx) as a valuable source of general population illicit drug use dataNg FL, Rockhill K, Black J, May KP, Whittington MD, Wood DM, Dargan PI, Green JLPostgrad Med J
Racial/ethnic differences in prevalence trends for heroin use and non-medical use of prescription opioids among entrants to Opioid Treatment Programs, 2005-2016Pouget ER, Fong C, Rosenblum ASubst Use Misuse
Prevention not Cure: Avoiding a European Prescription Opioid EpidemicSmith DC, Dart RC, Hirst CONdrugDelivery
Assessment of tapentadol API abuse liability with the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) SystemVosburg SK et al.J Pain
Unit-dose packaging and unintentional buprenorphine-naloxone exposuresWang GS, Severtson SG, Bau GE, Dart RC, Green, JLPeds
Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation StrategyBucher Bartelson B et al.Pharmacoepidemiol Drug Saf
Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findingsButtram et al.Pharmacoepidemiol Drug Saf
Understanding the demand side of the prescription opioid epidemic: does the initial source of opioids matter?Cicero TJ, Ellis MSDrug Alcohol Depend
Increased use of heroin as an initiating opioid of abuseCicero TJ, Ellis MS, Kasper ZA Addict Behav
Increases in self-reported fentanyl use among a population entering drug treatment: the need for systematic surveillance of illicitly manufactured opioidsCicero TJ, Ellis MS, Kasper ZADrug Alcohol Depend
Psychoactive substance use prior to the development of iatrogenic opioid abuse: A descriptive analysis of treatment-seeking opioid abusersCicero TJ, Ellis MS, Kasper ZAAddict Behav
Relative preferences in the abuse of immediate-release versus extended-release opioids in a sample of treatment-seeking opioid abusersCicero TJ, Ellis MS, Kasper ZAPharmacoepidemiol Drug Saf
Do abuse deterrent opioids work? Dart RC, Iwanicki JL, Dasgupta N, Cicero TJ, Schnoll SHJ Opioid Manag
Patterns of prescription drug use and misuse in Spain: The European Opioid Treatment Patient Survey Fonseca F et al.Heroin Addict Relat Clin Probl
Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administrationGreen et al.Drug Alcohol Depend
Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the RADARS System Web Monitoring ProgramVosburg et al.Pharmacoepidemiol Drug Saf
Assessment of tapentadol API abuse liability with the RADARS SystemVosburg SK, Severtson SG, Dart RC, Cicero TJ, Kurtz SP, Parrino MW, Green, JLJ Pain
A tale of 2 ADFs: differences in the effectiveness of abuse-deterrent formulations of oxymorphone and oxycodone extended-release drugsCicero TJ, Ellis MS, Kasper ZAPain
The prescription paradox of acetaminophen safetyDart RC, Green JLPharmacoepidemiol Drug Saf
Diversion and illicit sale of extended release tapentadol in the United StatesDart RC, Surratt HL, Le Lait MC, Stivers Y, Bebarta VS, Freifeld CC, Brownstein JS, Burke JJ, Kurtz SP, Dasgupta NPain Med
Abuse and diversion of immediate release opioid analgesics as compared to extended release formulations in the United StatesIwanicki JL et al.PLoS ONE
Opioid misuse in the 30 days prior to entering Agonist Opioid Treatment in four European Countries. A pilot studyMaremmani I et al.Heroin Addict Relat Clin Probl
Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodoneSevertson SG et al.Drug Alcohol Depend
Prescription opioid exposures and adverse outcomes among older adultsWest NA, Dart RCPharmacoepidemiol Drug Saf
Analysis of the abuse and diversion of the buprenorphine transdermal delivery systemWiegand TJ, Le Lait MC, Bucher Bartelson B, Dart RC, Green JLJ Pain
Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContinCicero TJ, Ellis MSJAMA Psychiatry
Abuse-deterrent formulations of prescription opioids [Letter to the Editor]Cicero TJ, Ellis MSJAMA Psychiatry
Shifting patterns of prescription opioid and heroin abuse in the United States [Letter to the Editor]Cicero TJ, Ellis MS, Harney JN Engl J Med
Trends in opioid analgesic abuse and mortality in the United StatesDart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher Bartelson B, Green JLN Engl J Med
Abuse-deterrent formulations of prescription opioids [Letter to the Editor]Dart RC, Severtson SG, Green JLJAMA Psychiatry
Characteristics of non-opioid substance misusers among patients enrolling in opioid treatment programs: a latent class analysisFong C, Matusow H, Cleland CM, Rosenblum AJournal of Addictive Diseases
Prescription opioids (substitution medications and pain medication) in patients looking for Opioid Agonist Treatment in Northern and Southern Italy, using a 18-month survey methodologyMaremmani I et al.Heroin Addict Relat Clin Probl
Trends in abuse and misuse of prescription opioids among older adultsWest NA, Severtson SG, Green JL, Dart RCDrug Alcohol Depend
The changing face of heroin use in the United States: a retrospective analysis of the past 50 yearsCicero TJ, Ellis MS, Surratt HL, Kurtz SPJAMA Psychiatry
Factors contributing to the rise of buprenorphine misuse: 2008-2013Cicero TJ, Ellis MS, Surratt HL, Kurtz SPDrug Alcohol Depend
Non-medical use of tapentadol immediate release by college studentsDart RC, Bucher Bartelson B, Adams EHClinical Journal of Pain
Seasonal variation in suicidal behavior with prescription opioid medicineDavis JM, Searles VB, Severtson G, Dart RC, Bucher-Bartelson BJournal of Affective Disorders
Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visitsDavis JM, Severtson SG, Bucher-Bartelson B, Dart RCPharmacoepidemiol Drug Saf
Abuse and diversion of buprenorphine sublingual tablets and filmLavonas EJ et al.Journal of Substance Abuse Treatment
Assessment of prescription opioid intentional exposures across the rural-urban continuum in the United States using both population and drug availability ratesLe Lait MC et al.Pharmacoepidemiol Drug Saf
Tamper-resistant opioid formulations in the treatment of acute painPassik SDAdvances in Therapy
Reductions in prescription opioid diversion following recent legislative interventions in FloridaSurratt HL, O'Grady C, Kurtz SP, Stivers Y, Cicero TJ, Dart RC, Chen MPharmacoepidemiol Drug Saf
Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United StatesCicero TJ, Ellis MS, Surratt HL, Kurtz SPPain
Crowdsourcing black market pricing of prescription opioidsDasgupta N, Freifeld C, Brownstein JS, Menone CM, Surratt HL, Poppish L, Green JL, Lavonas EJ, Dart RCJournal of Medical Internet Research
Prescription opioid abuse in the UK [Letter to the Editor]Giraudon I, Lowitz K, Dargan PI, Wood DM, Dart RCJournal of Clinical Pharmacology
The use of energy drinks, dietary supplements, and prescription medications by United States college students to enhance athletic performanceHoyte CO, Albert D, Heard KJJ Community Health
Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young childrenLavonas EJ, Banner W, Bradt P, Bucher-Bartelson B, Brown KR, Rajan P, Murrelle L, Dart RC, Green JLJournal of Pediatrics
Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United StatesSembower MA, Ertischek MD, Buchholtz C, Dasgupta N, Schnoll SHJournal of Addictive Diseases
Reduced abuse, diversion, and therapeutic errors following reformulation of OxyContin® in 2010Severtson SG, Bucher Bartelson B, Davis JM, Muñoz A, Schneider MF, Chilcoat H, Coplan PM, Surratt H, Dart RCThe Journal of Pain
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsSmith SM et al.Pain
Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-Related Surveillance (RADARS®) SystemZosel A et al.Journal of the American Academy of Child and Adolescent Psychiatry
Health outcomes and motivations of patients using no-prescription online pharmacies to purchase tramadolCicero TJ, Ellis MSJournal of Medical Internet Research
Effect of abuse-deterrent formulation of OxyContin [Letter to the Editor]Cicero TJ, Ellis MS, Surratt HLNew England Journal of Medicine
Patterns of prescription opioid abuse and comorbidity in an aging treatment populationCicero TJ, Surratt HL, Kurtz S, Ellis MS, Inciardi JAJournal of Substance Abuse Treatment
Assessment of the abuse of tapentadol immediate release: The first 24 monthsDart RC, Cicero TJ, Surratt HL, Rosenblum A, Bartelson BB, Adams EHJournal of Opioid Management
Using poison center exposure calls to predict methadone poisoning deathsDasgupta N, Davis J, Funk MJ, Dart RPLOS One
Do prescription monitoring programs impact state trends in opioid abuse/misuse?Reifler LM, Droz D, Bailey E, Schnoll SH, Fant R, Dart RC, Bucher Bartelson BPain Medicine
The role of key informants and direct patient interviews in epidemiological studies of substance abuseCicero TJ, Ellis MS, Paradis A, Ortbal ZPharmacoepidemiol Drug Saf
Multiple determinants of specific modes of prescription opioid diversionCicero TJ, Kurtz SP, Surratt HL, Ibanez GE, Ellis MS, Levi-Minzi MA, Inciardi JAJournal of Drug Issues
Age differences in heroin and prescription opioid abuse among enrollees into opioid treatment programsCleland CL, Rosenblum A, Fong C, Maxwell CSubstance Abuse Treatment, Prevention, and Policy
Interpreting poison center call volume associated with tramadol [Letter to the Editor]Dart RC, Dasgupta N, Bailey JE, Spiller HAThe Annals of Pharmacotherapy
Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutionsKatz N, Dart RC, Bailey E, Trudeau J, Osgood E, Paillard FThe American Journal of Drug and Alcohol Abuse
Distance traveled and cross-state commuting to opioid treatment programs in the United StatesRosenblum A, Cleland CM, Fong C, Kayman DJ, Parrino MJournal of Environmental and Public Health
Alternate routes of administration and risk for HIV among prescription opioid abusersSurratt H, Kurtz SP, Cicero TJJournal of Addictive Diseases
Determinants of fentanyl and other potent μ opioid agonist misuse in opioid dependent individualsCicero TJ, Ellis MS, Paradis A, Ortbal ZPharmacoepidemiol Drug Saf
Characteristics of prescription opioid abuse in the United States and CanadaCicero T, Inciardi JA, Surratt HL, Horbay G, Bordman J, Forster ICanadian Journal of Addiction Medicine
Post-marketing surveillance of methadone and buprenorphine in the United StatesDasgupta N, Bailey JE, Cicero T, Inciardi JA, Parrino M, Rosenblum A, Dart RCPain Medicine
Prescription drugs purchased through the internet: Who are the end users?Inciardi JA, Surratt HL, Cicero TJ, Rosenblum A, Ahwah C, Bailey JE, Dart RC, Burke JJDrug and Alcohol Dependence
Current trends in nonmedical use of prescription extended-release amphetamines and methylphenidateLindholm A, Varughese S, Sembower MA, Shiffman S, Schnoll SH, Ertischek MD, St. Jean E, Rosen SEuropean Psychiatry
Validity of self-reported misuse of prescription opioid analgesicsSmith MY, Rosenblum A, Parrino M, Fong C, Colucci SSubstance Use and Misuse
Investigation of temporal changes of abuse and misuse of prescription opioidsSpiller H, Bailey JE, Dart RC, Spiller SSJournal of Addictive Disease
The underrecognized toll of prescription opioid abuse on young childrenBailey JE, Campagna E, Dart RC, Reporting for the RADARS System Poison Center GroupAnnals of Emergency Medicine
Monitoring risk: Post marketing surveillance and signal detectionDart RCDrug and Alcohol Dependence
Prescription opioid abuse and diversion in an urban community: The results of an ultrarapid assessmentInciardi JA, Surratt HL, Cicero TJ, Beard RA Pain Medicine.
The ‘black box’ of prescription drug diversionInciardi JA, Surratt HL, Cicero TJ, Kurtz SP, Martin SS, Parrino MWJournal of Addictive Diseases
FDA approvals of generic drugs: Impact on the diversion of opioid analgesics with a potential for abuse Inciardi JA, Surratt HL, Cicero TJ, Kurtz SP, Martin SS, Parrino MWJournal of Opioid Management
Indicators of buprenorphine and methadone use and abuse: What do we know?Maxwell JC, McCance-Katz EFThe American Journal on Addictions
Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007Schneider, MF et al.Pharmacoepidemiol Drug Saf
Epidemiological trends in abuse and misuse of prescription opioidsSpiller H, Lorenz DJ, Bailey JE, Dart, RCJournal of Addictive Diseases
Toxicity of buprenorphine overdoses in childrenHayes BD, Klein-Schwartz W, Doyon SPediatrics
Detecting signals of opioid analgesic abuse: Application of a spatial mixed effect poisson regression model using data from a network of poison control centersSmith MY, Irish W, Wang J, Haddox J, Dart RCPharmacoepidemiol Drug Saf
The development of a comprehensive risk-management program for prescription opioid analgesics: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS® )Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Munoz APain Medicine
Trends in the use and abuse of branded and generic extended release oxycodone and fentanyl products in the United StatesCicero TJ, Inciardi JA, Surratt HLDrug and Alcohol Dependence
Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban and urban locations in the United StatesCicero TJ, Surratt HL, Inciardi JA, Munoz APharmacoepidemiol Drug Saf
Active surveillance of abused and misused prescription opioids using poison center data: A pilot study and descriptive comparisonHughes AA et al.Clinical Toxicology
The diversion of prescription opioid analgesicsInciardi JA, Surratt HL, Lugo Y, Cicero TJLaw Enforcement Executive Forum Journal
Prescription opioid abuse among enrollees into methadone maintenance treatmentRosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland C, Magura S, Haddox DDrug and Alcohol Dependence
Abuse of buprenorphine in the United States: 2003 – 2005Smith MY, Bailey JE, Woody GE, Kleber HDJournal of Addictive Diseases
Quantifying morbidity associated with the abuse and misuse of opioid analgesics: A comparison of two approachesSmith MY, Schneider MF, Wentz A, Hughes A, Haddox JD, Dart RCClinical Toxicology
The effect of FDA approval of a generic competitor to OxyContin (Oxycodone HCl Controlled-Release) tablets on the abuse of oxycodoneBailey JE, Barton PL, Lezotte D, Lowenstein SR, Dart RCDrug and Alcohol Dependence
The diversion of Ultram® , Ultracet® , and generic tramadol HClInciardi JA, Cicero TJ, Munoz A, Adams EH, Geller A, Senay EC, Woody GEJournal of Addictive Diseases
The diversion of prescription drugs by health care workers in Cincinnati, OhioInciardi JA, Surratt HL, Kurtz SP, Burke JJSubstance Use and Misuse
Clinician validation of poison control center intentional exposure cases involving prescription opioidsSmith MY, Dart RC, Hughes AA, Geller A, Senay EC, Woody GE, Colucci SAmerican Journal of Drug and Alcohol Abuse
Diversion and abuse of methadone prescribed for pain managementCicero TJ, Inciardi JAJournal of the American Medical Association
Trends of abuse in OxyContin® and other opioid analgesics in the United States: 2002- 2004Cicero TJ, Inciardi JA, Munoz AThe Journal of Pain
OxyContin® and prescription drug abusenciardi JA, Goode JLConsumers’ Research